Kyphoplasty and Vertebroplasty Market - Favourable Clinical Evidence and Penetration into New Markets to Drive Growth by GlobalData

VIEWS: 20 PAGES: 12

More Info
									           Kyphoplasty and Vertebroplasty Market - Favourable Clinical
           Evidence and Penetration into New Markets to Drive Growth
       Reference Code: GDME0763VPT                                                                                                Publication Date: September 2011

       1         Table of Contents
       1 Table of Contents.................................................................1
        1.1 List of Tables .................................................................1
        1.2 List of Figures ................................................................1
       2 Kyphoplasty and Vertebroplasty Market ..............................2
        2.1 Summary .......................................................................2
        2.2 Introduction....................................................................2
        2.3 Indications for Kyphoplasty and Vertebroplasty.............2
        2.4 Global Kyphoplasty and Vertebroplasty, Market
             Characterization ............................................................4
        2.5 Vertebroplasty vs. Kyphoplasty: Scenario before
             Publishing of New England Journal of Medicine’s
             Studies ..........................................................................5
        2.6 Impact of Studies Published in the New England
             Journal of Medicine on the Growth of Vertebroplasty
             and Kyphoplasty Market ................................................6
        2.7 Kyphoplasty and Vertebroplasty, Market Dynamics ......7
       3 Appendix ............................................................................10
        3.1 Research Methodology ...............................................11
        3.2 Secondary Research ...................................................11
        3.3 Primary Research........................................................11
        3.4 Models .........................................................................11
        3.5 Forecasts.....................................................................12
        3.6 Expert Panels ..............................................................12
        3.7 GlobalData Consulting ................................................12
        3.8 Contact Us...................................................................12
        3.9 Disclaimer....................................................................12

       1.1       List of Tables
       Table 1:   Percentage of Cancer Patients Suffering Vertebral
                  Compression Fractures Annually (the US), 2003 ....2
       Table 2: Kyphoplasty and Vertebroplasty Market, Global,
                  Revenue ($m), Historic, 2009 ─ 2010 ......................4
       Table 3: Kyphoplasty and Vertebroplasty Market, Global,
                  Revenue ($m), Forecast, 2010 ─ 2017 ....................4
       Table 4: Clinical Studies Showing Kyphoplasty and
                  Vertebroplasty Effectiveness ....................................8
       Table 5: Percentage of Population Aged 65 and Older, by
                  Country, 2005 ─ 2015 ..............................................9
       Table 6: Number of Neoplasm* Cases, the US, the UK,
                  Germany, 2006 ─ 2008 ............................................9
       Table 7: Kyphoplasty Settlements Between Hospitals and US
                  Federal Government, 2009 ─ 2011 ........................10

       1.2       List of Figures
       Figure 1: Kyphoplasty and Vertebroplasty Market, Global,
                 Revenue ($m), Historic, 2009 ─ 2010 ......................4
       Figure 2: Kyphoplasty and Vertebroplasty Market, Global,
                 Revenue ($m), Forecast, 2010 ─ 2017 ....................5
       Figure 3: Percentage of Population Aged 65 and Older, by
                 Country, 2005 ─ 2015 ..............................................9
       Figure 4: Number of Neoplasm* Cases, the US, the UK,
                 Germany, 2006 ─ 2008 ............................................9



                                                                                                                                                       Market Analysis Alert
Kyphoplasty and Vertebroplasty Market – Favourable Clinical                                                                                       GDME0763VPT / SEP 2011
                                                                                                                                                                    Page 1
Evidence and Penetration into New Markets to Drive Growth
                                                                                                   © GlobalData. This report is a licensed product and is not to be photocopied
                                                                            million annually. In Japan, the yearly incidence is greater than
                                                                            500,000.
       2         Kyphoplasty and Vertebroplasty
                                                                            VCF is caused by a number of factors. The most common
                 Market
                                                                            cause of VCF is osteoporosis, which accounted for nearly 73%
       2.1       Summary                                                    of VCF cases in 2006. Cancer and trauma accounted for 16%
                                                                            and 11% of VCF cases respectively.
       Kyphoplasty and Vertebroplasty procedures are indicated for
       treatment of Vertebral Compression Fractures (VCFs). In 2010,        Osteoporosis
       the global kyphoplasty and vertebroplasty market was valued at       Osteoporosis is caused by low bone mass and structural
       $733.6m, registering a modest 2% growth over 2009. This was          deterioration of bone tissue. It is commonly associated with old
       due to two studies published in August, 2009, in the New             age. Due to impaired activity of osteoblast and osteoclast cells,
       England Journal of Medicine (NEJM) questioning the benefits          the rate of bone formation drastically reduces and the bone
       offered by vertebroplasty procedures. These studies have             resorption rate increases. Osteoporosis commonly affects the
       resulted in an immediate decline in the procedure volumes and        spine. The ability of the spine to withstand compressive loads
       adversely impacted the third and fourth quarter revenues of          becomes impaired due to increased bone porosity and
       major players in the vertebroplasty and kyphoplasty market in        decreased bone strength, gradually leading to VCF.
       2009. But the favorable clinical studies which followed the
       studies published in the NEJM and the gaining of marketing           Osteoporosis is also a common problem in women post-
       approval in new geographies such as Japan are expected to            menopause due to changes in endogenous hormone levels. In
       push the market back onto growth path.                               t
								
To top